Qubit Pharmaceuticals Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Olema Oncology.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | |
Founding Date | Founding Date 1981 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations San Francisco, US HQ San Francisco, US |
Employees | Employees 277161% increase | Employees 9630% increase |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 679.2 m |
Financial | ||
Net income | Net income ($222.9m) (FY, 2022) | Net income ($162.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 145.1m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company